Understanding the Revised Psychotropic Quality Measure Changes – Part 1
CMS has revised the Quality Measure that tracks psychotropic medication used by skilled nursing facilities. This interactive session will describe the data structure and changes to the foundation data that creates the performance statistics. Topics will be discussed for the entire interdisciplinary team to increase awareness of data definitions and documentation requirements. Examples of case studies will illustrate how the new claims data use will impact facilities' regulatory, audit, and payment processes.
The change in data used to calculate the Quality Measure report requires that the facility's operational and clinical team work with their pharmacy provider and Medical Director to understand the QM reports. This will be the first of a two-part program to assist facility leadership in adapting to these changes. This is a must-attend session with resources and training materials for leadership.
Tuesday, July 21, 2026
1:00 pm ET
Presented by:
Leah Klusch RN, BSN, FACHCA, Executive Director of The Alliance Training Center
Casey Andrews, PharmD, Consultant Pharmacist, PharMerica
Learning Objectives:
1. Identify the data set and claims data utilized to calculate the current QM reports.
2. Discuss the importance of structure of the interdisciplinary team's involvement in data formulation and data accuracy at the facility.
3. Describe specific issues related to regulatory, audit, and compliance for the interdisciplinary team with the input from the consultant pharmacist.
.
CE Statement:
This program has been approved for 1 participant hour of nursing continuing education, as well as by NAB/NCERS (approval# 20270701-1-A122227-DL) for nursing home administrators, and by NABP for pharmacists. Provider (Pedagogy, Inc) approved by the California Board of Registered Nursing, Provider #: CEP 15467 for 1.00 Contact Hours. Attendees must have been in attendance for at least 50 minutes to receive credit.
REGISTER NOW: